Ratings Elders Limited

Equities

ELD

AU000000ELD6

Delayed Australian S.E. Other stock markets 12:58:08 2024-05-07 am EDT			5-day change	1st Jan Change
8.46 ^AUD	+2.79%		-0.35%	+12.35%

May. 02	Elders Acquires Tasmania, Australia-Based Real Estate Network IPST	MT
May. 01	Elders Limited acquired IPST Holdings.	CI

Strengths

The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.52 for the 2024 fiscal year.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Analyst opinion has improved significantly over the past four months.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
The company does not generate enough profits, which is an alarming weak point.
Revenue estimates are regularly revised downwards for the current and coming years.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Fishing & Farming

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
ELDERS LIMITED	+12.35%	857M		C+
SITEONE LANDSCAPE SUPPLY, INC.	-2.70%	7.15B		C+
HEILONGJIANG AGRICULTURE COMPANY LIMITED	+12.36%	3.32B		C-
LIMONEIRA COMPANY	+1.79%	378M		B-
PT NUSANTARA SAWIT SEJAHTERA TBK	+11.30%	293M		-
BIOTALYS NV	-33.62%	107M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes